Scientific Publications

Legend Biotech sponsors research with academic institutions to evaluate our agents. The manuscripts from this research are presented below.

Year :

Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma with 2-4 Prior Lines of Therapy: Updated Matching-Adjusted Indirect Comparison

Nieves Lopez-Muñoz, Noffar Bar, Joris Diels, Suzy van Sanden , João Mendes, Seina Lee, Teresa Hernando, Nikoletta Lendvai, Nitin Patel, Tadao Ishida, Jeremy Er, Simon J Harrison

Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial

Nieves Lopez-Muñoz, Noffar Bar, Joris Diels, Suzy van Sanden , João Mendes, Seina Lee, Teresa Hernando, Nikoletta Lendvai, Nitin Patel, Tadao Ishida, Jeremy Er, Simon J HarrisonHermann Einsele , Jesús San-Miguel , Binod Dhakal , Cyrille Touzeau , Xavier Leleu , Niels Wcj van de Donk , Surbhi Sidana , Albert Oriol , Yael C Cohen , Simon J Harrison , María-Victoria Mateos , Joaquín Martínez-López , Paolo Corradini , Lionel Karlin , Diana Chen , Quanlin Li , Tzu-Min Yeh , Katherine Li , Vicki Plaks , Ana Slaughter , Carolina Lonardi , Nina Benachour , Arnab Ghosh , Martin Vogel , Jordan M Schecter , Nikoletta Lendvai , Mythili Koneru , Nitin Patel , Erika Florendo , Phoebe Joy Ho , Rakesh Popat 

Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4

Paula Rodríguez-Otero , Surbhi Sidana , Mathilde Kouwenhoven , Jordan M Schecter , Nikoletta Lendvai , Kevin C De Braganca , Ana Slaughter , Carolina Lonardi , Philip Vlummens , Helen Varsos , Christina Corsale , Deepu Madduri , Hao Zhao , Katherine Li , Erin Lee , Loreta Marquez , Man Zhao , Tzu-Min […]

Survival Outcomes with Cilta-cel Versus Conventional Treatment Regimens for Patients with Lenalidomide-Refractory Multiple Myeloma Using Inverse Probability of Treatment Weighting

Rafael Fonseca , Joris Diels , Francesca Ghilotti , João Mendes , Sandra Van Hoorenbeeck , Seina Lee , Jordan M Schecter , Nikoletta Lendvai , Nitin Patel , Ana Triguero , Winfried Alsdorf , Niels W C J van de Donk , Margherita Ursi

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

Sundar Jagannath, Thomas G Martin, Yi Lin, Adam D Cohen, Noopur Raje, Myo Htut, Abhinav Deol, Mounzer Agha, Jesus G Berdeja, Alexander M Lesokhin, Jessica J Liegel, Adriana Rossi, Alex Lieberman-Cribbin, Saad Z Usmani, Binod Dhakal, Samir Parekh, Hui Li, Feng Wang, Rocio Montes de Oca, Vicki Plaks, Huabin Sun, Arnob Banerjee, Jordan M Schecter, […]

close

You are about to leave LegendBiotech.com

You are going to a website that Legend Biotech does not operate and to which Legend Biotech's privacy policy does not apply. Legend Biotech is not responsible for the content, format, maintenance or policies of the website you are about to visit and does not endorse or monitor any content on such website.

We use cookies to improve your experience on our website, measure performance, understand our audience, for advertising and support purposes. You can always change your preferences or opt out from our use of cookies.